September 2023

  • All
  • --
  • ---
  • -2022
  • 2022-2
  • 2022-2-2-2
  • 2022-deltia-tipoy
  • 2022-deltia-tipoy-2-2
  • 2022-deltia-tipoy-2-2-2-2
  • 2023-deltia-typou
  • 2023-deltia-typou-2-2
  • 2024
  • 257-2
  • 257-2-2-2
  • 266-2
  • Announcements
  • Consolidated Financial Results
  • deltia-tipoy
  • deltia-tipoy-2-2
  • deltia-tipoy-2-2-2-2
  • Distribution of Divident
  • Events
  • FAQ
  • General Meetings and Corporate Actions
  • Insiders Transactions Disclosures
  • Invitations
  • invitations-2
  • Presentations
  • Press Kits
  • Press Releases
  • Regulated Information
  • Results 2024
  • Share Capital Increase
  • Uncategorized

Peania, 21 September 2023– Lavipharm (LAVI) reports a significant increase in consolidated sales and EBITDA during the First Half of 2023. The impressive results exceed sales forecasts, as disclosed in the prospectus of the recent share capital increase, for a second consecutive year. Specifically, consolidated Sales,...

Peania, 19 September 2023 - Lavipharm joins voices with MDA Hellas, that organizes a unique concert featuring the leading singer-songwriter Nikos Portokaloglou and the renowned singer Rena Morfi. The concert will take place tomorrow, 20 September (21.00) at the Veakio Municipal Theatre of Piraeus. The concert...

Peania, 7 September 2023 – Lavipharm, a long-time supporter of MDA Hellas, the Association for the Care of People with Neuromuscular Diseases, is participating as a sponsor in the online event that will take place today, September 7, 2023, at 17:00, organized in the framework...

Παιανία, 7 Σεπτεμβρίου 2023 - Η Lavipharm, διαχρονικός αρωγός του MDA Ελλάς, Σωματείο Φροντίδας Ατόμων με Νευρομυϊκές Παθήσεις, συμμετέχει ως χορηγός στη διαδικτυακή εκδήλωση που θα πραγματοποιηθεί σήμερα,  7 Σεπτεμβρίου 2023, στις 17:00, στο πλαίσιο της 10ης Παγκόσμιας Ημέρας Ευαισθητοποίησης για τη Μυϊκή Δυστροφία Duchenne...